- define more lenses than are already available;
- discuss what types of lenses can be developed;
- discuss implementation strategies.
Register now – participation is free of charge.
To recognize and celebrate the most promising contributions, three prizes will be awarded.
The Design Award 5,000 €
honors excellence in user-centered design solution with high innovation potential & market impact
The Innovation Award 2,500 €
highlights bold, forward-looking ideas that advance digital health
The Impact Award 2,500 €
acknowledges the solution with the strongest potential to generate meaningful benefits for patients and healthcare systems
WHAT ARE THE GOALS OF THIS HACKATHON?
The Gravitate Health project, now in its fifth and final year, has developed a federated open-source platform (FOSP). The goal of Gravitate Health is to empower and equip Europeans with health information for active personal health management and adherence to treatment.
Visit Gravitate Health‘s website to Learn more:
The Hackathon provides a great opportunity to showcase the platform and invite participants to test its usability and build on it and contribute to its improvement. Constructive feedback on further development and new ideas will be very valuable.
The ePI (electronic product information), interoperability, and the FHIR standard are in the center of development of the FOSP, one of the main outputs of Gravitate Health.
Among the aims of the project is also to stimulate public-private partnerships to:
(i) Create market-specific applications which can accommodate specific needs of national or local ecosystems.
(ii) Build commercial solutions to serve specific disease areas and add value to the platform.
By creating lenses, you will contribute to the sustainability of Gravitate Health vision opening opportunities for the creation of new markets.
The Hackathon is held in Athens, at Divani Caravel Hotel, at the city centre.
Remote participation in the Hackathon is open, and we encourage individuals to join online or even teams to form in remote locations and connect to the event in Athens.
Divani Caravel Hotel | 2, Vasileos Alexandrou Av., 16121, Athens, Greece
In the context of Gravitate-Health project, one of the most prominent objectives is to provide patients with the information they need about their medications. However, this information needs to be adapted to the context and preferences of the end-user to achieve effective and optimal understanding.
A lot of progress has been made since Hackathon #1, and now there are many annotated ePIs, the Gravitate Health Implementation Guide (IG), and several lenses.
At Hackathon #2 the challenge will be to design more lenses and contribute with more ideas on lenses-i.e. how to personalise medicines information.
More specifically, to Develop G-lenses (a ‘G-lens®’ is a piece of code which encodes certain knowledge required to better adapt the content of product information) using:
(1) the Gravitate Health FOSPS*,
(2) ePIs with embedded semantic annotations (using standard terminologies such as SNOMED-CT, LOINC, ICD 10, iCPC-2),
(3) a persona vector i.e., the information relevant to the patient’s health in an International Patient Summary-IPS, and
(4) the patient’s current context and preferences; create a lens that effectively and optimally adapts the content to preferences and context to provide the patient with relevant information about his/her medicines.
*FOSPS: federated open-source platform services
Find out more details here:
SUPPORTING ORGANISATIONS
SPONSORS
Subscribe to our newsletter
Supported by a grant from IMI
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 945334. The JU receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA], and Datapharm Limited. The total budget is 19.4M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects Project owner’s views and neither IMI nor the European Union, EFPIA, or or Datapharm Limited are liable for any use that may be made of the information contained herein.